PI3K/AKT and the downstream mTOR/S6 kinase were reported important for activating the translation of PD-L1 protein in variant types of cancers, including non-small cell lung cancer [45], prostate cancer [46], glioma [47], as well as in TNBC [44]. Here, MTOR is linked to prostate carcinoma.